<style type="text/css"> .wpb_animate_when_almost_visible { opacity: 1; }</style>
  • Using technology in tumor genomics to develop precision cancer therapeutics

    Investor Relations

Press Releases

Archives: Search / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012

2013 Archives

Nov 14, 2013
First clinical results presented on novel molecular diagnostics to optimize cancer treatment; Ends quarter with approximately $28 million in cash
Oct 21, 2013
Initial data from ongoing clinical study presented by MD Anderson Cancer Center and Trovagene at AACR-NCI-EORTC International Conferences highlights promise of urine-based, cell-free diagnostics
Oct 14, 2013
Findings from studies investigating clinical validity of non-invasive cancer-mutation monitoring platform will be shared for first time at AACR-NCI-EORTC conference on October 21, 2013
Oct 1, 2013
Cell-free DNA assay transferred to CLIA laboratory for patient testing
Sep 6, 2013
Study to investigate Trovagene's non-invasive cancer monitoring technology using cell-free DNA from urine samples
Sep 4, 2013
Rodman & Renshaw 15th Annual Global Healthcare Conference and Stifel Healthcare Conference 2013
Jul 29, 2013
Digital PCR system adoption helps create ultra-sensitive cell-free DNA assay
Jul 24, 2013
Patent covers methods of detecting cell-free microRNA in urine and blood
Jul 22, 2013
Trovagene develops ultra-sensitive cell-free DNA assay
Jun 27, 2013
Presentation scheduled on June 27, 2013 at 9:20 a.m. ET in New York
Jun 3, 2013
Presentation scheduled on June 6, 2013 at 3:00 p.m. ET in New York
Mar 27, 2013
New, non-invasive molecular diagnostic test is easy, fast, and accurate
Mar 12, 2013
Presentation scheduled on March 19, 2013 at 12:00 p.m. PT at the Ritz-Carlton Laguna Nigel, in Dana Point, CA
Feb 5, 2013
Presentation scheduled on February 13, 2013 at 9:00 a.m. ET at the Waldorf Astoria in New York City

email print rss
Wistia video thumbnail - Susann-Berz Patient Video- Home Page

Thanks for reporting a problem. We'll attach technical data about this session to help us figure out the issue. Which of these best describes the problem?

Any other details or context?